Insider Cluster (2 insiders) ·Filed Jul 2, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago
Insider cluster: 2 insiders, $425K total
Actionable Insight • Neutral

This is a routine option-exercise-and-sell cluster by the CEO and EVP/GC, representing ~0.03% of market cap. No bearish signal. Monitor for any upcoming 8-K or press release that might have triggered the exercise timing, but the pattern is consistent with standard post-vesting liquidity. No trade action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Latest settled — T+60d ⚠ clustered
UTHR ▼ -15.06% at T+60d
NEUTRAL call ✗ call lost -15.06% · α vs SPY -18.06% · entry $555.91 → $472.21
Next anchor: T+1d due 3mo ago
Entry anchored
Jul 1, 03:59 PM ET
via exchange tick
T+1d
—
call — · α —
—
due 3mo ago
T+5d
-0.62%
call -0.62% · α -1.55%
$552.48
settled 3mo ago
T+20d
-5.41%
call -5.41% · α -5.00%
$525.82
settled 2mo ago
T+60d
-15.06%
call -15.06% · α -18.06%
$472.21
settled 7d ago

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt and EVP/GC Paul Mahon executed a cluster of open-market sales on July 2, 2026, totaling approximately $8.1M in proceeds. The sales were overwhelmingly driven by the exercise and immediate sale of stock options, a routine pattern for insiders at a $23.2B market cap company. The total value represents ~0.03% of market cap, well below the 0.1% threshold for materiality, making this a routine liquidity event with no bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$8.1M
Insiders
2

Key Facts

  • CEO Martine Rothblatt and EVP/GC Paul Mahon sold a combined ~$8.1M in open-market sales on July 2, 2026.
  • Both insiders simultaneously exercised stock options (Rothblatt: 9,500 shares at $0; Mahon: 8,300 shares at $146.03) and sold the resulting shares — a classic cashless exercise pattern.
  • Total open-market sales of ~$8.1M represent ~0.03% of UTHR's $23.2B market cap, well below the 0.1% materiality threshold.
  • The cluster is entirely sell-side with no open-market purchases, but the pattern is consistent with routine option exercise-and-sell for tax/expense purposes, not informed selling.

Financial Impact

Total open-market sales of ~$8.1M represent ~0.03% of UTHR's $23.2B market cap — trivial and routine.

insider ownershipdilution

Risk Factors

  • Insider sales could accelerate if the stock continues to trade near all-time highs above $550.
  • No open-market purchases to offset the selling signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1783058999873
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 3, 2026